R
Robert F. Reilly
Researcher at Veterans Health Administration
Publications - 89
Citations - 5920
Robert F. Reilly is an academic researcher from Veterans Health Administration. The author has contributed to research in topics: Kidney disease & Distal convoluted tubule. The author has an hindex of 37, co-authored 87 publications receiving 5456 citations. Previous affiliations of Robert F. Reilly include University of Alabama at Birmingham & University of Colorado Denver.
Papers
More filters
Journal ArticleDOI
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried,Nicholas V. Emanuele,Nicholas V. Emanuele,Jane H. Zhang,Mary Brophy,Todd A. Conner,William C. Duckworth,William C. Duckworth,David J. Leehey,David J. Leehey,Peter A. McCullough,Theresa Z. O'Connor,Paul M. Palevsky,Robert F. Reilly,Stephen L. Seliger,Stuart R. Warren,Suzanne Watnick,Peter Peduzzi,Peter Peduzzi,Peter Guarino +19 more
TL;DR: Combination therapy with an ACE inhibitor and an ARB was associated with an increased risk of adverse events among patients with diabetic nephropathy and safety outcomes included mortality, hyperkalemia, and acute kidney injury.
Journal ArticleDOI
NHE3: a Na+/H+ exchanger isoform of renal brush border
Daniel Biemesderfer,John H. Pizzonia,Ali K. Abu-Alfa,Markus Exner,Robert F. Reilly,Peter Igarashi,Peter S. Aronson +6 more
TL;DR: Immunocytochemical studies confirmed that the Na+/H+ exchanger isoform NHE3 is expressed along the microvillar membrane of the brush border of proximal tubule cells in the rabbit kidney.
Journal ArticleDOI
Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy.
TL;DR: Molecular and functional results are integrated to provide a contemporary picture of distal tubule function in mammals and suggest that the basic molecular architecture of the distal nephron is surprisingly similar in mammalian species investigated to date.
Journal ArticleDOI
Hypophosphatemia: an evidence-based approach to its clinical consequences and management
TL;DR: With the exception of ventilated patients, there is little evidence that moderate hypophosphatemia has significant clinical consequences in humans, and aggressive intravenous phosphate replacement is unnecessary; by contrast, patients with severe hypoph phosphatemia should be treated.
Journal ArticleDOI
What nephrologists need to know about gadolinium
TL;DR: Gadolinium chelates have been associated with artifactual results of laboratory tests, acute kidney injury and nephrogenic systemic fibrosis, complications that seem to exclusively affect people with impaired renal function.